BML Investment Partners, L.P. - 09 Dec 2025 SCHEDULE 13D/A Report for Adverum Biotechnologies, Inc. Common Stock, par value $0.0001 per share (ADVM)

Filing Manager
BML Investment Partners, L.P.
Reporting Manager
BML Investment Partners, L.P.
Security
Adverum Biotechnologies, Inc. Common Stock, par value $0.0001 per share
Symbol
ADVM
Disclosed Ownership
0 shares
Ownership
0%
Form type
SCHEDULE 13D/A
Filing time
09 Dec 2025, 18:05:36 UTC
Date of event
09 Dec 2025
Previous filing
05 Dec 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"BML Investment Partners, L.P. disclosed 0% ownership in Adverum Biotechnologies, Inc. Common Stock, par value $0.0001 per share (ADVM) on 09 Dec 2025."

Quick Takeaways

  • BML Investment Partners, L.P. filed SCHEDULE 13D/A for Adverum Biotechnologies, Inc. Common Stock, par value $0.0001 per share (ADVM).
  • Disclosed ownership: 0%.
  • Date of event: 09 Dec 2025.

What Changed

  • Previous schedule filing date: 05 Dec 2025.
  • Current filing was accepted on 09 Dec 2025, 18:05.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
BML Investment Partners, L.P. 0% 0 0 0 Braden M Leonard Braden M Leonard - Managing Member of BML Capital Management, LLC 0001373604
Leonard Braden Michael 0% 0 0 Braden M Leonard Leonard Braden Michael 0001373603

Sponsored